Novel Polθ Inhibitors for BRCA-deficient Cancers (IMAGE)

InSilico Medicine

Novel Polθ Inhibitors for BRCA-deficient Cancers

Caption

Researchers used both ligand-based drug design (LBDD) and structure-based drug design (SBDD) strategies within the Chemistry42 generative chemistry engine for molecular generation. 

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.